Adaptive Biotechnologies (ADPT) Amortization - Intangibles (2018 - 2026)

Adaptive Biotechnologies has disclosed Amortization - Intangibles across 9 years of filings, most recently posting $419000.0 for Q1 2026.

• Amortization - Intangibles for Q1 2026 came in at $419000.0, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.7 million (changed 0.0% YoY), and the FY2025 annual result was $1.7 million, changed 0.23% from the prior year.
• Amortization - Intangibles came in at $419000.0 for Q1 2026 at Adaptive Biotechnologies, down from $429000.0 in the prior quarter.
• In the past five years, Amortization - Intangibles ranged from a high of $429000.0 in Q4 2022 to a low of $419000.0 in Q1 2022.
• The 5-year median for Amortization - Intangibles is $424000.0 (2024), against an average of $424647.1.
• Across the five-year window, Amortization - Intangibles gained 0.95% in 2024 and declined 0.95% in 2025, its largest moves.
• Adaptive Biotechnologies' Amortization - Intangibles stood at $429000.0 in 2022, then changed by 0.0% to $429000.0 in 2023, then fell by 0.23% to $428000.0 in 2024, then advanced by 0.23% to $429000.0 in 2025, then fell by 2.33% to $419000.0 in 2026.
• The last three Amortization - Intangibles figures came in at $419000.0 (Q1 2026), $429000.0 (Q4 2025), and $428000.0 (Q3 2025), per Business Quant data.